viernes, 15 de mayo de 2015

Orphanet Journal of Rare Diseases | Abstract | Impact of imiglucerase supply constraint on the therapeutic management and course of disease in French patients with Gaucher disease type 1

Orphanet Journal of Rare Diseases | Abstract | Impact of imiglucerase supply constraint on the therapeutic management and course of disease in French patients with Gaucher disease type 1

Orphanet Journal of Rare Diseases

Read Rare Disease Day 2015 series







Orphanet Journal of Rare Diseases is an open access, online journal that encompasses all aspects of rare diseases and orphan drugs. The journal publishes high-quality reviews on specific rare diseases. In addition, the journal may consider articles on clinical trial outcome reports, either positive or negative, and articles on public health issues in the field of rare diseases and orphan drugs.

Editor-in-Chief

  • Ségolène Aymé, Hopital Broussais, INSERM

Society affiliations

The official journal of Orphanet, the portal for rare diseases and orphan drugs.


No hay comentarios:

Publicar un comentario